MicroRNA: a connecting road between apoptosis and cholesterol metabolism (Q38815056)

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Increasing the thermosensitivity of a mammary tumor (CA755) through dietary modification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Serum total and HDL cholesterol and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Serum cholesterol and testicular cancer incidence in 45,000 men followed for 25 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

The role of cholesterol in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Dysregulation of the mevalonate pathway promotes transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Lipid metabolism in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Apoptosis and cancer: the genesis of a research field

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Role of cholesterol and lipid organization in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA Regulation of Cholesterol Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

13C-labelling studies indicate compartmentalized synthesis of triacylglycerols in C6 rat glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Apoptosis-induced mitochondrial dysfunction causes cytoplasmic lipid droplet formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Caspases: pharmacological manipulation of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Mechanisms of caspase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Programmed cell death in animal development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Apoptosis: a review of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

STL-based analysis of TRAIL-induced apoptosis challenges the notion of type I/type II cell line classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Apoptosis in cancer: from pathogenesis to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between “triple-negative” and non–“triple-negative” tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Frequent downregulation of Fas (CD95) expression and function in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Apoptosis and molecular targeting therapy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Clinical implications of p53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Apoptosis: Silencing the death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Apoptosis and cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

APP binds DR6 to trigger axon pruning and neuron death via distinct caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Mutant Huntingtin induces activation of the Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Autophagy and apoptosis dysfunction in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Cell death in the pathogenesis of heart disease: mechanisms and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Mitochondrial involvement in cardiac apoptosis during ischemia and reperfusion: can we close the box?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Coxiella burnetii modulates Beclin 1 and Bcl-2, preventing host cell apoptosis to generate a persistent bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: a role for HBV-induced HCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Caveolin-1 as a potential new therapeutic target in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Cholesterol is essential for mitosis progression and its deficiency induces polyploid cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Effects of distal cholesterol biosynthesis inhibitors on cell proliferation and cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Atherosclerosis. the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

SREBPs: physiology and pathophysiology of the SREBP family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

microRNAs and cholesterol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Liver X receptors as integrators of metabolic and inflammatory signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Cellular fatty acid metabolism and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Regulation and deregulation of cholesterol homeostasis: The liver as a metabolic "power station".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Diabetes contributes to cholesterol metabolism regardless of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Cholesterol involvement in the pathogenesis of neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Cholesterol homeostasis: a key to prevent or slow down neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

ATP citrate lyase is an important component of cell growth and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Statin lipid-lowering drugs and bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

High Cholesterol Deteriorates Bone Health: New Insights into Molecular Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Cholesterol induces pancreatic β cell apoptosis through oxidative stress pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Free cholesterol-induced macrophage apoptosis is mediated by inositol-requiring enzyme 1 alpha-regulated activation of Jun N-terminal kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Lipid droplet and milk lipid globule membrane associated placental protein 17b (PP17b) is involved in apoptotic and differentiation processes of human epithelial cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

An investigation of human brain tumour lipids by high-resolution magic angle spinning 1H MRS and histological analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Many roads to maturity: microRNA biogenesis pathways and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Most mammalian mRNAs are conserved targets of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miRBase: annotating high confidence microRNAs using deep sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA regulation of core apoptosis pathways in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNAs in cell proliferation, cell death, and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNAs as regulators of differentiation and cell fate decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

A developmental view of microRNA function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNAs and metabolism crosstalk in energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNAs: a connection between cholesterol metabolism and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

LNA-mediated microRNA silencing in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

A regulatory role for microRNA 33* in controlling lipid metabolism gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MiR-33 contributes to the regulation of cholesterol homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miR-33 links SREBP-2 induction to repression of sterol transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Anti-atherosclerosis or No Anti-atherosclerosis: That is the miR-33 question

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

The proto-oncogene Pim-1 is a target of miR-33a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Mir-33 regulates cell proliferation and cell cycle progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Upregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Integrated mRNA and micro RNA profiling reveals epigenetic mechanism of differential sensitivity of Jurkat T cells to AgNPs and Ag ions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Radon-induced alterations in micro-RNA expression profiles in transformed BEAS2B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRα expression and cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 acute lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Effect of miR-128 in DNA damage of HL-60 acute myeloid leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Downregulation of miRNA-128 sensitises breast cancer cell to chemodrugs by targeting Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Repression of ATR pathway by miR-185 enhances radiation-induced apoptosis and proliferation inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-185 regulates chemotherapeutic sensitivity in gastric cancer by targeting apoptosis repressor with caspase recruitment domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Phospho-ΔNp63α regulates AQP3, ALOX12B, CASP14 and CLDN1 expression through transcription and microRNA modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

The microRNA-342-5p fosters inflammatory macrophage activation through an Akt1- and microRNA-155-dependent pathway during atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Obesity-Associated MiR-342-3p Promotes Adipogenesis of Mesenchymal Stem Cells by Suppressing CtBP2 and Releasing C/EBPα from CtBP2 Binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

A microRNA component of the p53 tumour suppressor network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miR-34a repression of SIRT1 regulates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Transcriptional activation of miR-34a contributes to p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Down-regulation of microRNA-34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Frequent downregulation of miR-34 family in human ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNAs in metabolism and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

SIRT1 deacetylates and positively regulates the nuclear receptor LXR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Down-regulation of miR-106b suppresses the growth of human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Regulating A549 cells growth by ASO inhibiting miRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Down‐regulation of microRNA 106b is involved in p21‐mediated cell cycle arrest in response to radiation in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MiR-106b and MiR-15b modulate apoptosis and angiogenesis in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA regulation of Alzheimer's Amyloid precursor protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Downregulation of miR-23a and miR-27a following experimental traumatic brain injury induces neuronal cell death through activation of proapoptotic Bcl-2 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

GT-094, a NO-NSAID, Inhibits Colon Cancer Cell Growth by Activation of a Reactive Oxygen Species-MicroRNA-27a: ZBTB10-Specificity Protein Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Role of microRNA-27a in down-regulation of angiogenic factor AGGF1 under hypoxia associated with high-grade bladder urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-23a/b and microRNA-27a/b suppress Apaf-1 protein and alleviate hypoxia-induced neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA miR-27b rescues bone marrow-derived angiogenic cell function and accelerates wound healing in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MiR-27a targets sFRP1 in hFOB cells to regulate proliferation, apoptosis and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MiR-27a regulates apoptosis in nucleus pulposus cells by targeting PI3K

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3θ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Upregulation of miR-23a-27a-24-2 cluster induces caspase-dependent and -independent apoptosis in human embryonic kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Ionizing radiation-inducible miR-27b suppresses leukemia proliferation via targeting cyclin A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

(6)-Gingerolinduced myeloid leukemia cell death is initiated by reactive oxygen species and activation of miR-27b expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Regulation of ABCA1 protein expression and function in hepatic and pancreatic islet cells by miR-145.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-27a regulates beta cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor beta1 in neonatal rat ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNAs play a role in spontaneous recovery from acute liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miR-122 does not modulate the elongation phase of hepatitis C virus RNA synthesis in isolated replicase complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Retracted: miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miR-122 targets NOD2 to decrease intestinal epithelial cell injury in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Regulation and biological function of the liver-specific miR-122.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Treatment of HCV infection by targeting microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Context-Dependent Bidirectional Regulation of the MutS Homolog 2 by Transforming Growth Factor β Contributes to Chemoresistance in Breast Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Non-phosphorylated FTY720 Induces Apoptosis of Human Microglia by Activating SREBP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Androgen receptor signaling in prostate cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Is Cancer a Genetic Disease or a Metabolic Disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Molecular pathways: sterols and receptor signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Another small molecule in the oncometabolite mix: L-2-Hydroxyglutarate in kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

High-density lipoproteins and cardiovascular disease: 2010 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Osteoblast-derived Oxysterol Is a Migration-inducing Factor for Human Breast Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Statins as modulators of bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Novel biological functions of high-density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Mitochondria, cholesterol and amyloid beta peptide: a dangerous trio in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

RhoA and p38 MAPK mediate apoptosis induced by cellular cholesterol depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

HMG-CoA reductase inhibitors induce apoptosis in pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

MiR-27 orchestrates the transcriptional regulation of brown adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and -independent manner via PUMA-Bak axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miR2Disease: a manually curated database for microRNA deregulation in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4988-Z

miR-106b is overexpressed in medulloblastomas and interacts directly with PTEN.

21 January 2018

1 reference

12 December 2020

Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis

1 reference

12 December 2020

miR-27a as an oncogenic microRNA of hepatitis B virus- related hepatocellular carcinoma

1 reference

12 December 2020

MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.

1 reference

12 December 2020

Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer

1 reference

12 December 2020

Lentiviral expression of anti-microRNAs targeting miR-27a inhibits proliferation and invasiveness of U87 glioma cells

1 reference

12 December 2020

Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation

1 reference

12 December 2020

Expression and function of miR-27b in human glioma

1 reference

12 December 2020

Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production

1 reference

12 December 2020

Clinical applications of microRNAs

1 reference

12 December 2020

Apoptosis in autoimmune diseases

1 reference

12 December 2020

Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines.

1 reference

12 December 2020

miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer

1 reference

12 December 2020

The effects of pravastatin, an HMG-CoA reductase inhibitor, on cell viability and DNA production of rat hepatocytes

1 reference

12 December 2020

Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia

1 reference

12 December 2020

Oxysterols induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 protein downregulation

1 reference

12 December 2020

Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells

1 reference

12 December 2020

Lovastatin-induced apoptosis in prostate stromal cells

1 reference

12 December 2020

MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.

1 reference

12 December 2020

microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma

1 reference

12 December 2020

A matter of life and death

1 reference

12 December 2020

Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation

1 reference

12 December 2020

Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease.

1 reference

12 December 2020

Selective activation of the fatty acid synthesis pathway in human prostate cancer

1 reference

12 December 2020

Ultrastructural localization of prostaglandin endoperoxide synthase (cyclooxygenase) to isolated, purified fractions of guinea pig peritoneal macrophage and line 10 hepatocarcinoma cell lipid bodies

1 reference

12 December 2020

Deregulation of cell death (apoptosis): implications for tumor development.

1 reference

12 December 2020

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture

1 reference

12 December 2020

MiRNA-based therapy: from bench to bedside

1 reference

12 December 2020

MicroRNA-27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages

1 reference

12 December 2020

Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo

1 reference

12 December 2020

Apoptosis and autoimmune diseases

1 reference

12 December 2020

Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of amyloid-beta peptide

1 reference

12 December 2020

Oxysterol-induced apoptosis in human monocytic cell lines

1 reference

12 December 2020